文献速递瓣膜病与结构性心脏病血脂与心血管预防

急性风湿热中失调的IL-1β-GM-CSF轴及羟氯喹的抑制作用

Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine.
PubMed 文献 · Circulation · 2018-01-01

该研究分析澳大利亚原住民急性风湿热(ARF)患者外周血单核细胞对A组链球菌的免疫反应,发现IL-1β-GM-CSF轴失调,表现为IL-1β持续产生、GM-CSF过度产生及CXCR3+CCR4-CCR6-CD4 T细胞选择性扩增,且ARF患者血清CXCL10升高;羟氯喹可有效抑制该反应,提示其或可降低ARF后风湿性心脏病风险。

要点

  • ARF患者PBMC暴露于A组链球菌后出现IL-1β-GM-CSF轴失调。
  • CXCR3+CCR4-CCR6-CD4 T细胞是GM-CSF主要来源,ARF血清CXCL10升高。
  • 羟氯喹可抑制IL-1β驱动的GM-CSF表达CD4 T细胞扩增。

核心结论

  • ARF中存在失调的IL-1β-GM-CSF轴,羟氯喹可有效抑制该反应,或可重新定位用于降低ARF后风湿性心脏病风险。

研究设计与样本

  • 研究分析澳大利亚原住民ARF队列外周血单核细胞,采用多重细胞因子阵列、流式细胞术和RNA测序全局基因表达分析,并测试羟氯喹对该反应的影响。

主要发现

  • ARF外周血单核细胞在体外暴露于A组链球菌后,持续产生IL-1β并 coupled 于GM-CSF过度产生及CXCR3+CCR4-CCR6-CD4 T细胞选择性扩增。
  • CXCR3+CCR4-CCR6-CD4 T细胞是人CD4 T细胞中GM-CSF的主要来源,ARF患者血清中CXCL10升高。
  • IL-1β可放大表达GM-CSF的CD4 T细胞扩增,羟氯喹有效抑制该扩增。
  • RNA测序显示不同临床阶段ARF患者外周血单核细胞基因表达谱和差异表达基因发生改变。

临床怎么用

  • 基于羟氯喹的安全性及其在类风湿关节炎等自身免疫病中的临床经验,可考虑将其重新定位用于ARF后降低风湿性心脏病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute rheumatic fever (ARF) and rheumatic heart disease are autoimmune consequences of group A streptococcus infection and remain major causes of cardiovascular morbidity and mortality around the world. Improved treatment has been stymied by gaps in understanding key steps in the immunopathogenesis of ARF and rheumatic heart disease. This study aimed to identify (1) effector T cell cytokine(s) that might be dysregulated in the autoimmune response of patients with ARF by group A streptococcus, and (2) an immunomodulatory agent that suppresses this response and could be clinically translatable to high-risk patients with ARF. METHODS: The immune response to group A streptococcus was analyzed in peripheral blood mononuclear cells from an Australian Aboriginal ARF cohort by a combination of multiplex cytokine array, flow cytometric analysis, and global gene expression analysis by RNA sequencing. The immunomodulatory drug hydroxychloroquine was tested for effects on this response. RESULTS: We found a dysregulated interleukin-1β-granulocyte-macrophage colony-stimulating factor (GM-CSF) cytokine axis in ARF peripheral blood mononuclear cells exposed to group A streptococcus in vitro, whereby persistent interleukin-1β production is coupled to overproduction of GM-CSF and selective expansion of CXCR3+CCR4-CCR6- CD4 T cells. CXCR3+CCR4-CCR6- CD4 T cells are the major source of GM-CSF in human CD4 T cells and CXCL10, a CXCR3 ligand and potent T helper 1 chemoattractant, was elevated in sera from patients with ARF. GM-CSF has recently emerged as a key T cell-derived effector cytokine in numerous autoimmune diseases, including myocarditis, and the production of CXCL10 may explain selective trafficking of these cells to the heart. We provide evidence that interleukin-1β amplifies the expansion of GM-CSF-expressing CD4 T cells, which is effectively suppressed by hydroxychloroquine. RNA sequencing showed shifts in gene expression profiles and differentially expressed genes in peripheral blood mononuclear cells derived from patients at different clinical stages of ARF. CONCLUSIONS: Given the safety profile of hydroxychloroquine and its clinical pedigree in treating autoimmune diseases such as rheumatoid arthritis, where GM-CSF plays a pivotal role, we propose that hydroxychloroquine could be repurposed to reduce the risk of rheumatic heart disease after ARF.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Kim ML, Martin WJ, Minigo G, et al. Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine. Circulation. 2018. PMID: 30571257. doi:10.1161/CIRCULATIONAHA.118.033891

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。